The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Abstract
ADVERTISEMENT RETURN TO ISSUEReviewNEXTContemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer ChemotherapyChristian Bailly*View Author Information Centre de Recherche et Développement, Institut de Recherche Pierre Fabre, 3 Avenue Hubert Curien, BP 13562, 31035 Toulouse cedex 1, France*E-mail: [email protected]Cite this: Chem. Rev. 2012, 112, 7, 3611–3640Publication Date (Web):March 8, 2012Publication History Received20 August 2011Published online8 March 2012Published inissue 11 July 2012https://pubs.acs.org/doi/10.1021/cr200325fhttps://doi.org/10.1021/cr200325freview-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views6871Altmetric-Citations238LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Cells,Genetics,Inhibitors,Peptides and proteins,Toxicity Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–209 of 209
Lin, B., Chen, Z., Xu, Y. F., Zhang, H., Liu, J., & Qian, X. H. (2011) · Leukemia Research · doi:10.1016/j.leukres.2011.01.029 · Cited by 13
Nakeff, A., Sahay, N., Pisano, M., & Subramanian, B. (2001) · Cytometry · doi:10.1002/cyto.10038 · Cited by 12
Evison, B. J., Pastuovic, M., Bilardi, R. A., Forrest, R. A., Pumuye, P. P., Sleebs, B. E., Watson, K. G., Phillips, D. R., & Cutts, S. M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.013 · Cited by 12
Synthetic lanostane-type triterpenoids as inhibitors of DNA topoisomerase II
Wada, S., & Tanaka, R. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.052 · Cited by 11
Inhibitory effects of docosyl p-coumarate on DNA topoisomerase activity and human cancer cell growth
Mizushina (2010) · International Journal of Oncology · doi:10.3892/ijo_00000750 · Cited by 11
Reiners, J. J., Kleinman, M. D., Joiakim, A., & Mathieu, P. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144808 · Cited by 11
Qi, S.-N., Jing, Y.-X., Dong, G., et al. (2007) · Oncology Reports · doi:10.3892/or.18.1.273 · Cited by 7
Boinpally, R., Zhou, S.-L., LoRusso, P. M., & Parchment, R. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0862-6 · Cited by 7
Tachibana, Y., Zhu, X., Krishnan, P., Lee, K., & Bastow, K. F. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200001000-00004 · Cited by 5
Cited by
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
Marinello, J., Delcuratolo, M., & Capranico, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113480 · Cited by 258
Metadata
- Authors
- Bailly, C.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-03-08
- Volume
- 112
- Issue
- 7
- Pages
- 3611-3640
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2326231942
- Cited by
- 288
- References
- 209
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.